Harmony Biosciences (HRMY) has the highest short interest by a US stock in the Pharmaceuticals Industry, with 50.91% of float sold short (6.459M shares).
ASSET | SHARES SHORT | FLOAT | SHORT % OF FLOAT | SHORT RATIO |
---|---|---|---|---|
Harmony Biosciences (HRMY) | 6.459M | 34.6305M | 50.91% | 15.08 |
Phathom Pharmaceuticals (PHAT) | 12.032M | 43.2299M | 42.24% | 13.35 |
Cassava Sciences (SAVA) | 12.844M | 40.2249M | 31.93% | 15.17 |
Innoviva (INVA) | 11.5205M | 50.9985M | 29.99% | 16.52 |
Corcept Therapeutics (CORT) | 21.1223M | 85.3125M | 28.67% | 24.85 |
Collegium Pharmaceutical (COLL) | 6.9869M | 28.7993M | 26.4% | 14.42 |
Theravance Biopharma (TBPH) | 6.4297M | 15.8649M | 26.03% | 14.32 |
Adial Pharmaceuticals (ADIL) | 1.0097M | 3.9377M | 25.75% | .14 |
Enliven Therapeutics (ELVN) | 4.6401M | 19.54M | 24.87% | 10.05 |
Omeros (OMER) | 13.1325M | 51.7109M | 23.7% | 30.67 |
Tarsus Pharmaceuticals (TARS) | 7.8996M | 22.5584M | 21.68% | 13.48 |
Verrica Pharmaceuticals (VRCA) | 3.8361M | 15.0505M | 20.46% | 22.54 |
Aurora Cannabis (ACB) | 8.1419M | 54.3904M | 20.42% | .59 |
Harrow Health (HROW) | 5.922M | 26.4795M | 20.07% | 9.44 |
Axsome Therapeutics (AXSM) | 7.7486M | 34.9082M | 19.62% | 11.26 |
Eyepoint Pharmaceuticals (EYPT) | 6.536M | 30.3075M | 17.89% | 9.02 |
CorMedix (CRMD) | 9.3769M | 54.4312M | 17.06% | 12.43 |
Liquidia Technologies (LQDA) | 8.0739M | 49.9555M | 16.56% | 8.72 |
Scilex (SCLX) | 7.3446M | 51.1971M | 16.01% | 8.47 |
Scpharmaceuticals (SCPH) | 4.7821M | 16.4977M | 15.79% | 20.67 |
Tilray (TLRY) | 118.7261M | 770.4757M | 15.41% | 2.36 |
Ventyx Biosciences (VTYX) | 8.376M | 41.2173M | 13.92% | 5.98 |
Arvinas (ARVN) | 8.9423M | 52.43M | 13.33% | 12.65 |
Eyenovia (EYEN) | 5.3788M | 36.6163M | 13.06% | 3.19 |
Supernus Pharmaceuticals (SUPN) | 4.6811M | 47.7365M | 12.88% | 10.84 |